Lumen Bioscience logo

Lumen Bioscience

lumen.bio

Lumen Bioscience engineers the edible algae spirulina to produce therapeutic proteins for orally delivered biologic drugs, as well as ingredients for human and animal nutrition. Its platform is intended to make biologic medicines faster and less costly to develop and more accessible to patients.

Facts

HQ
Seattle
Sectors
Biotechnology Research
Founded
2017
Type
Corporation Seattle business license
Employees
104
Registered name
Lumen Bioscience Inc Seattle business license
Stage
Series C
Founders
Brian Finrow, Jim Roberts

Is this your organization? Claim it

Lumen Bioscience adds Jeff Raikes to board, promotes executives and secures $30M Series C extension led by WestRiver Group

Lumen Bioscience announced board and leadership changes—including Jeff Raikes joining as an independent director, promotions of Nhi Khuong and Kole Krieger, and appointment of David Saunders—and elected Erik Anderson as Vice Chairman. The company also closed an oversubscribed $30 million Series C extension led by WestRiver Group with participation from the Gates Foundation and several new investors to support its orally delivered biologics clinical pipeline.

See all 10 news stories about Lumen Bioscience.

People

  • Brian Finrow
    Brian Finrow Co-Founder and Chief Executive Officer
  • Jim Roberts Co-Founder and Chief Scientific Officer

Online